Get started
Author

Cristiana Costa Chase

Anaplastic Multiple Myeloma: Case Series and Literature Review
2022 · Jian Wu, Emily Chu, et al. · Asploro Journal of Biomedical and Clinical Case Reports · 15
PDF
Initial Results of Dose Escalation of ISB 1342, a Novel CD3xCD38 Bispecific Antibody, in Patients with Relapsed / Refractory Multiple Myeloma (RRMM)
2022 · Sanjay R Mohan, Cristiana Costa Chase, et al. · Blood · 14
Dose Escalation of ISB 1342, a Novel CD38xCD3 Bispecific Antibody, in Patients with Relapsed / Refractory Multiple Myeloma (RRMM)
2023 · Prashant Kapoor, Don A. Stevens, et al. · Blood · 12
A cross-sectional observational study of health-related quality of life in adults with multiple myeloma
2022 · Matthew R. LeBlanc, Ashley Leak Bryant, et al. · Supportive Care in Cancer · 9
Light-Chain Pericardial Amyloidosis Emerging Alongside Variant Transthyretin Cardiac Amyloidosis
2024 · Alexander H. Gunn, Johana Fajardo, et al. · JACC CardioOncology · 3
Immune profiling of smoldering multiple myeloma patients treated in a phase lb study of PVX-410 vaccine targeting XBP1/CD138/CS1 antigens, and citarinostat, a histone deacetylase inhibitor (HDACi) with and without lenalidomide
2025 · Diana Cirstea, Rajib Shome, et al. · Blood Cancer Journal · 2
PDF
Treatment Patterns, Efficacy, and Tolerability of Belantamab Mafodotin in Patients With Relapsed and/or Refractory Multiple Myeloma: A Real-World Analysis
2025 · Mihir N. Patel, Susan C. Locke, et al. · Clinical Lymphoma Myeloma & Leukemia · 2
The Hematologist's Role in Amyloidosis Management: Disease Awareness, Diagnostic Workup, and Practice Patterns
2020 · Anita D'Souza, Keren Osman, et al. · Blood · 2
Musculoskeletal Adverse Events Following BCMA CAR T-Cell Therapy in Multiple Myeloma: Clinical Characteristics and Immune Correlates
2026 · Amber Feng, Jian Wu, et al. · Transplantation and Cellular Therapy · 1
Characterizing and Risk Stratifying Musculoskeletal Toxicities after BCMA CAR-T Therapy for Relapsed/Refractory Multiple Myeloma
2024 · Amber Feng, Taewoong Choi, et al. · Blood · 1
PDF
Cardiac Biomarker Complete Response in Light Chain Amyloidosis
2026 · Alexander H. Gunn, Cristiana Costa Chase, et al. · JACC CardioOncology
Bridging Therapy's effects on clinical outcomes after commercial BCMA CAR T-cell therapy used in the standard of care treatment of relapsed and refractory multiple myeloma
2025 · Kimberly Burcher, Amber Feng, et al. · Blood
Immune Profiling and Responses of Smoldering Multiple Myeloma Patients Treated in a Phase Ib Study of Pvx-410 Vaccine Targeting XBP1/CD138/CS1 Antigens, and Citarinostat, a Histone Deacetylase Inhibitor (HDACi) with and without Lenalidomide
2023 · Diana Cirstea, Rajib Shome, et al. · Blood
PDF
Works count: 13
Citation count: 61
H-index: 4
I10-index: 3
Year
Topic
Type